Pharma & Bio
Technology
Stock Market Marks 'Nickjeon Day'… Chilly Winds Blow Through KOSDAQ Biotech Market [Bio Spotlight]
On the 22nd, on the Korea Composite Stock Price Index (KOSPI), SamsungElectronics(005930)—which had held the top spot in market capitalization for 24 years—ceded its throne to SK hynix(000660). On tha…
Lifestyle
ECM Skin Boosters Are Popping Up Everywhere—What Are the Two Key Factors to Distinguish the Good from the Bad?
Competition is intensifying as skin boosters based on human tissue-derived extracellular matrix (ECM) are reshaping the market. With the ECM skin booster market expected to continue growing, securing …
Manufacturing
YuyuPharma’s ‘Triple Growth’... Earnings Make a Quantum Leap Thanks to B2C Pet Business in the U.S.
YuyuPharma(000220)has continued its earnings growth trend since the start of this year. Analysts attribute this to improved profitability resulting from streamlined production processes and an optimiz…
Technology
Cg MedTech Hits Daily Price Limit...Hair Loss Stocks Rally on Hopes for Insurance Coverage [K-Bio Pulse]
On June 19, shares of South Korean medical device maker Cg MedTech surged to the daily upper limit on Thursday following reports that its parent company, regenerative medicine specialist CGBio, could …
Technology
CG MedTech Rises on Acquisition by Largest Shareholder, a Private Equity Firm… Hair Loss Stocks SAMIK PHARM. Co., LTD. and JW SHINYAK CORPORATION Also Up [Bio Spotlight]
On the 19th, among domestic pharmaceutical and biotech stocks, the share prices of Innosys(056090), #SAMIK PHARM. Co., LTD., and JW SHINYAK CORPORATION(067290)rose significantly. CG MedTech hit its da…
Lifestyle
Setting Their Sights on a Second Celltrion... The “Troika” of Small but Strong CDMOs Shining Amid an Earnings-Driven Market
The paradigm of the domestic pharmaceutical and biotech investment market is shifting. The era of an expectation-driven market—where market capitalization would fluctuate by trillions of won based on …
Business·Industry
Halozyme’s ‘Target Agreement’ vs. Alteogen Inc.’s ‘Compound Agreement’… Why Alteogen Inc. Is Smiling
Alteogen Inc.(196170)’s partner, Merck (MSD), has invalidated Halozyme’s MDASE patent in a Post-Grant Review (PGR) before the U.S. Patent Trial and Appeal Board (PTAB), removing a hurdle to Alteogen I…
Lifestyle
FC303 Narrowly Avoided Repeating Medy-Tox Inc.’s Mistakes… FutureChem Co., Ltd.: “Currently in Technology Transfer Negotiations with Two European Companies”
FutureChem Co., Ltd.(220100)has terminated its European technology transfer agreement for “FC303,” a radiopharmaceutical for prostate cancer diagnosis, even while covering the research and development…
Lifestyle
"Overcame the Cancer Barrier That Even Immunotherapy Couldn’t Break"… Will KOLON LIFE SCIENCE Inc. Shake Up the Head and Neck Cancer Treatment Market?
A tumor disappeared after just a single dose. This is the result of preclinical research on KLS-3021, which KOLON LIFE SCIENCE Inc.(102940)presented last April at the American Association for Cancer R…
Manufacturing
BL Pharmtech Shares Hit Upper Limit as Expectations Grow for Technology Transfer Deal [K-Bio Pulse]
On June 18, shares of BL PharmTech, JLK, and Raphas stood out in the domestic pharmaceutical and biotechnology stock market with strong gains. In particular, BL PharmTech surged to the daily price lim…